Cristiane Bergerot: We Can Treat Painful Neuropathy, But Can We Prevent It?

Cristiane Bergerot, Head of the Department of Psycho-Oncology at Grupo Oncoclínicas, Brazil, posted on X:

“We can treat painful neuropathy, but can we prevent it?

This trial shows duloxetine (30 or 60 mg) did not reduce OIPN vs placebo.

Back to the drawing board.”

Title: Alliance A221805: Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II Study

Authors: Ellen M. Lavoie Smith, Minji Lee, Mary R. Scott, Heshan Liu, Shauna Hillman, Tracy Rieken, Rachel Wills, Julian Diaz-Cobo, Selina Chow, Heidi D. Finnes, Kathryn Ruddy, Jeffrey Meyerhardt, Eileen O’Reilly, Tareq Al Baghdadi, Narjust Florez, Jordan Kharofa, Rang Govindarajan, Mohamedtaki Tejani, Ki Chung, David Zahrieh, Charles Loprinzi, Maryam Lustberg

Read here.

Cristiane Bergerot
Other articles about Duloxetine on OncoDaily.